
Cell Culture Media 2.0
Next-generation culture media for optimized protein glycosylation, superior cell growth, and target cell morphology
Our Service
CUSTOM MEDIA DEVELOPMENT
Standard culture media serve general purposes, but every cell clone has unique nutritional requirements.
We design culture media specifically for your cell line—enhancing growth, morphology, and protein expression.
Our innovative platform—the first of its kind—customizes and delivers optimized media for each cell clone within weeks.
Please contact us.


Our Company
There is a German expression that says: “You are what you eat!” This is just as true for cells. Cells become what they metabolize—what we give them through culture media. Media composition influences everything: cell growth, morphology, productivity, and product quality.
This idea has fascinated Dr. Aziz Cayli for 27 years. With great enthusiasm, he began exploring cellular metabolism and the impact of nutrients.


His first breakthrough, ActiCHO, culture medium, became the best-selling CHO media worldwide.
Driven by this passion, Dr. Cayli founded Florabio in 2016 —focusing solely on cell culture media development. Since then, Florabio has developed a wide portfolio of high-performance media.Florabio continues to develop custom and next-generation media tailored to evolving needs.
Management


Dr. Aziz Cayli
Founder & CEO
Developed ActiCHO Medium and licensed out to GE Helath Care
Founder & CEO of company Cellca GmbH. Cellca sold to Sartotius
Head of cell culture media and process development at Boehringer Ingelheim, Germany.
Cell culture media and process development at Roche, Germany


Dr. Christopher Klein
Advisory Board
Partner
Steinbeis M&A Partners
Global Business Develpment
Novartis & Sandoz
Chief Corporate Development
Hameln Pharma
Prokurist in Health Science
Ernst & Young


Harry Brack
Advisory Board
Founder & CEO
Capricorn Scientific
Sales representant
GIBCO BRL
Founder & CEO
PAA laboratories, sold to GE Health Care






